Cargando…
The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial
INTRODUCTION: Alzheimer's disease (AD) is a continuum with neuropathologies manifesting years before clinical symptoms; thus, AD research is attempting to identify more disease-modifying approaches to test treatments administered before full disease expression. Designing such trials in cognitiv...
Autores principales: | Burns, Daniel K., Chiang, Carl, Welsh-Bohmer, Kathleen A., Brannan, Stephen K., Culp, Meredith, O'Neil, Janet, Runyan, Grant, Harrigan, Patrick, Plassman, Brenda L., Lutz, Michael, Lai, Eric, Haneline, Stephen, Yarnall, David, Yarbrough, Deborah, Metz, Craig, Ponduru, Sridevi, Sundseth, Scott, Saunders, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838537/ https://www.ncbi.nlm.nih.gov/pubmed/31720367 http://dx.doi.org/10.1016/j.trci.2019.09.010 |
Ejemplares similares
-
TOMMORROW neuropsychological battery: German language validation and normative study
por: Romero, Heather R., et al.
Publicado: (2018) -
Effects of pioglitazone on mnemonic hippocampal function: A blood oxygen level–dependent functional magnetic resonance imaging study in elderly adults
por: Knodt, Annchen R., et al.
Publicado: (2019) -
A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease
por: Lutz, Michael W., et al.
Publicado: (2016) -
TOMM40 ‘523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOE
ɛ3 Homozygotes
por: Watts, Amber, et al.
Publicado: (2023) -
Characterization of APOE and TOMM40 allele frequencies in the Japanese population
por: Nishimura, Akira, et al.
Publicado: (2017)